IV golimumab for juvenile idiopathic arthritis in shows effective risk-benefit profile: Study Jacinthlyn Sylvia26 Sept 2024 8:00 PM ISTA new study published in the Journal of Rheumatology unveiled that intravenous golimumab for juvenile idiopathic arthritis in a long-term extension...
CRP to albumin ratio indicates disease activity in juvenile idiopathic arthritis patients: Study Jacinthlyn Sylvia24 Aug 2024 6:30 AM ISTA new study by Giulia Di Donato and team found that in individuals with juvenile idiopathic arthritis (JIA), the neutrophil to lymphocyte ratio (NLR)...
High-dose etanercept helps children with juvenile idiopathic arthritis achieve remission and reduce disease activity: Study Dr Riya Dave28 May 2024 9:45 PM ISTResearchers have found that high-dose etanercept could help children with juvenile idiopathic arthritis (JIA) reduce disease activity and achieve...
Lupin unveils Rymti biosimilar Etanercept in Canada Ruchika Sharma5 May 2024 10:00 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Rymti, Lupin's first biosimilar in Canada, through its partner Sandoz...
Rheumatic diseases associated with childbearing problems, claims research Dr. Kamal Kant Kohli1 April 2024 3:00 AM ISTA new paper in Rheumatology, published by Oxford University Press, finds that rheumatic diseases can lead to reproductive problems, though some...
Laser flare photometry readings may identify uveitis associated with juvenile idiopathic arthritis Dr. Shravani Dali5 Feb 2024 3:00 AM ISTLaser flare photometry readings may identify uveitis associated with juvenile idiopathic arthritis suggests a new study published in the Pediatric...
Juvenile Idiopathic Arthritis: Symptoms, Diagnosis and Treatment- Dr Anurag Bansal Dr Anurag Bansal21 Oct 2023 11:02 AM ISTIntroductionJuvenile Idiopathic Arthritis (JIA) is a chronic inflammatory joint condition that affects children under the age of 16. Formerly known as...
MSN Labs gets CDSCO panel nod to manufacture, market Tofacitnib Oral Solution Dr. Divya Colin22 Jun 2023 4:40 PM ISTNew Delhi: Granting waivers for local clinical trials and bioavailability/bioequivalence (BA/BE) studies, the Subject Expert Committee (SEC)...
Etanercept safe, efficacious and tolerable for juvenile idiopathic arthritis: CLIPPER study. Dr.Niharika Harsha B23 May 2023 8:30 PM ISTNew research revealed that Etanercept medication for up to 10 years was well tolerated, consistent with the established safety profile, and resulted...
USFDA nod to citrate free high concentration formulation of biosimilar Hyrimoz injection: Sandoz Ruchika Sharma22 March 2023 1:45 PM ISTSandoz intends to launch the Hyrimoz citrate-free HCF in the US on July 1, 2023.
CDSCO Panel grants Pfizer's protocol amendment proposal for Tofacitinib Dr. Divya Colin25 Dec 2022 4:42 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the protocol...
Lupin gets Health Canada nod for plaque psoriasis treatment Rymti Ruchika Sharma13 Sept 2022 2:19 PM ISTMumbai: Global pharma major, Lupin Limited, announced today that Health Canada has approved Rymti, its biosimilar to Enbrel (etanercept), for use in...
